bluebird bio (BLUE)
(Delayed Data from NSDQ)
$0.91 USD
-0.01 (-1.13%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $0.91 0.00 (-0.27%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/14/2024
Time: -- |
3/2024 | $-0.47 | 4.93% |
Earnings Summary
For their last quarter, bluebird bio (BLUE) reported earnings of -$0.66 per share, beating the Zacks Consensus Estimate of $-0.69 per share. This reflects a positive earnings surprise of 4.35%. Look out for BLUE's next earnings release expected on May 14, 2024. For the next earning release, we expect the company to report earnings of -$0.47 per share, reflecting a year-over-year decrease of 323.81%.
Earnings History
Price & Consensus
Zacks News for BLUE
bluebird (BLUE) Underperforms Industry YTD Amid Challenges
BLUE: What are Zacks experts saying now?
Zacks Private Portfolio Services